Finnish Maternity Cohort Serum Bank
Initiatives
-
Use of the FMC enables follow-up and longitudinal research of risk factors and biomarkers associated to a disease of interest in the mother or in the child born after the pregnancy in question.
- Start Year
- 1983
- Supplementary Information
- https://dceg.cancer.gov/news-events/events/dceg-seminar-surcel#:~:text=The%20Finnish%20Maternity%20Cohort%20(FMC,and%20the%20Medical%20Birth%20Register.
Visit FMC
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Population cohort
- Supplementary Information
- https://pubmed.ncbi.nlm.nih.gov/29071810/
Marker Paper
Lehtinen M, Surcel HM, Natunen K, Pukkala E, Dillner J. Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohort. Cancer Med. 2017 Dec;6(12):3060-3064. doi: 10.1002/cam4.1222
PUBMED 29071810
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 2,000,000
- Number of participants with biosamples
- Supplementary Information
- Women
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |